Nirmit Arora

Nirmit Arora is a Founder of Ritivel, a Y Combinator W26 startup that transforms clinical trial data into FDA submission documents using an AI-native regulatory platform. Co-founded with Gunin Gupta and Pavan Kalyan Tankala in 2025, Ritivel emphasizes 100% reproducibility and word-level traceability for accuracy and security in regulated industries. Ritivel AI Private Limited was incorporated in Bangalore, India on December 10, 2025, helping pharmaceutical and biotech companies streamline regulatory submissions.

Ritivel is an AI-native regulatory platform for life sciences that automates the creation of FDA submission documents. The platform transforms raw clinical trial data into complete regulatory documents such as Clinical Study Reports (CSRs) and CTD modules in minutes rather than the traditional 8-12 weeks of manual work. What sets Ritivel apart is its 100% reproducibility (same input always produces the same output), word-level traceability linking every generated sentence to clinical evidence, and 100% on-premise deployment to keep sensitive patient data within the client's infrastructure. The platform addresses the "last mile" of drug development, a problem that generic AI tools cannot solve because they lack understanding of regulatory standards and FDA requirements. Clinical development is pharma's biggest bottleneck, with trial timelines increasing 33% over the last decade despite rising R&D spend. By accelerating clinical timelines by 20%, companies can unlock hundreds of millions in additional revenue per drug through extended patent life.